Mai Capital Management Charles River Laboratories International, Inc. Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$204.13 - $302.4 $82,672 - $122,471	405 Added 7.26%	5,987 $1.28 Million
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $108,336 - $153,534	-424 Reduced 7.06%	5,582 $1.59 Million
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $89,601 - $114,413	-255 Reduced 4.07%	6,006 $2.26 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $14,905 - $18,332	-40 Reduced 0.63%	6,261 $2.58 Million
Q2 2021 Jul 19, 2021	BUY	$294.17 - $371.65 $1,176 - $1,486	4 Added 0.06%	6,301 $2.33 Million
Q1 2021 May 10, 2021	BUY	$249.67 - $299.48 $9,487 - $11,380	38 Added 0.61%	6,297 $1.83 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $22,200 - $25,262	-100 Reduced 1.57%	6,259 $1.56 Million
Q3 2020 Oct 26, 2020	SELL	$175.56 - $226.45 $134,654 - $173,687	-767 Reduced 10.76%	6,359 $1.44 Million
Q2 2020 Jul 27, 2020	SELL	$118.84 - $189.72 $66,906 - $106,812	-563 Reduced 7.32%	7,126 $1.24 Million
Q1 2020 Apr 16, 2020	BUY	$98.9 - $178.34 $12,857 - $23,184	130 Added 1.72%	7,689 $970,000
Q4 2019 Feb 03, 2020	SELL	$126.05 - $152.76 $23,949 - $29,024	-190 Reduced 2.45%	7,559 $1.16 Million
Q3 2019 Oct 29, 2019	BUY	$125.07 - $143.67 $12,882 - $14,798	103 Added 1.35%	7,749 $1.03 Million
Q2 2019 Aug 15, 2019	SELL	$123.4 - $148.55 $60,959 - $73,383	-494 Reduced 6.07%	7,646 $1.09 Million
Q1 2019 Apr 29, 2019	SELL	$104.82 - $146.73 $78,300 - $109,607	-747 Reduced 8.41%	8,140 $1.18 Million
Q4 2018 Jan 30, 2019	SELL	$105.09 - $137.23 $59,165 - $77,260	-563 Reduced 5.96%	8,887 $1.01 Million
Q3 2018 Oct 12, 2018	SELL	$112.11 - $134.54 $45,404 - $54,488	-405 Reduced 4.11%	9,450 $1.27 Million
Q2 2018 Aug 16, 2018	SELL	$102.37 - $117.25 $16,379 - $18,760	-160 Reduced 1.6%	9,855 $1.11 Million
Q1 2018 Apr 17, 2018	SELL	$98.19 - $115.2 $20,325 - $23,846	-207 Reduced 2.03%	10,015 $1.07 Million
Q4 2017 Jan 30, 2018	BUY	$100.43 - $118.09 $3,715 - $4,369	37 Added 0.36%	10,222 $1.12 Million
Q3 2017 Oct 12, 2017	BUY	$96.72 - $109.26 $750,160 - $847,420	7,756 Added 319.31%	10,185 $1.1 Million
Q2 2017 Aug 07, 2017	BUY	N/A	2,429	2,429 $246,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.18 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$985 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$724 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$412 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$375 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.84B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account